Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliary tract neoplasms: update 2003.

David Malka1, Valérie Boige, Clarisse Dromain

  • 1Unité de Gastroentérologie, Institut Gustave Roussy, Villejuif, France.

Current Opinion in Oncology
|June 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026
Same author

Optimization of hypovascular liver lesion detectability in dual-energy CT using deep learning image reconstruction: a phantom study for potential iodine dose reduction.

European radiology experimental·2026
Same author

Optimal MRI sequence for predicting extraprostatic extension in prostate cancer: comparison of LCC and MaxRADD measurements.

Abdominal radiology (New York)·2026
Same author

Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids.

Journal of neuroendocrinology·2026
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Biliary tract cancers are aggressive, but recent advances in imaging and surgical techniques offer better diagnosis and treatment. New drug combinations and targeted therapies show promise for improving patient outcomes.

Area of Science:

  • Oncology
  • Gastroenterology
  • Surgical Oncology

Background:

  • Biliary tract neoplasms are highly aggressive malignancies with a poor prognosis.
  • Diagnosis often occurs after the cancer has spread, limiting curative resection options.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of biliary tract cancer.
  • To explore emerging therapeutic strategies and their potential impact on patient outcomes.

Main Methods:

  • Review of recent literature on biliary tract cancer diagnosis and treatment.
  • Analysis of new imaging modalities, surgical techniques, and chemotherapeutic agents.
  • Evaluation of biological studies focusing on carcinogenesis and targeted therapies.

Related Experiment Videos

Main Results:

  • Advances in imaging facilitate earlier diagnosis and improved surgical planning.
  • Enhanced surgical techniques have improved patient outlooks.
  • Photodynamic therapy and gemcitabine-based chemotherapy, particularly gemcitabine-oxaliplatin, show promise.
  • Biological studies reveal insights into carcinogenesis, paving the way for targeted therapies.

Conclusions:

  • Biliary tract cancer remains aggressive, but progress in diagnostics and therapeutics offers hope.
  • Continued research into targeted therapies and combination treatments is crucial for improving prognosis.